MGMojtaba Golpich

Mojtaba Golpich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mojtaba Golpich has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Firas Kobeissy

    Center for Neurotrauma, Multiomics & Biomarkers, Department of Neurobiology and Neuroscience Institute, Morehouse School of Medicine (MSM), Atlanta, Georgia

    3 shared publications
  • Hamad Yadikar

    Department of Biological Sciences, Faculty of Science, Kuwait University, Sabah Al Salem University City, Kuwait City, Kuwait

    2 shared publications
  • Jiepei Zhu

    Center for Neurotrauma, Multiomics & Biomarkers (CNMB), Department of Neurobiology & Neuroscience Institute, Morehouse School of Medicine, Atlanta, USA

    2 shared publications
  • Joy Solomon

    Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, USA

    2 shared publications
  • Kevin K. Wang

    Center for Neurotrauma, Multiomics & Biomarkers (CNMB), Department of Neurobiology & Neuroscience Institute, Morehouse School of Medicine, Atlanta, USA

    2 shared publications
  • Moyinoluwa Adeniyi

    Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, USA

    2 shared publications

Latest Publications

  • Open Access

    Millimeter-wave directed energy-mediated neural cell injury: insights into protein degradation and cell injury mechanisms

    by Mojtaba Golpich, Hamad Yadikar, Talib B. Saafir, Sherifdeen Onigbinde, Joy Solomon, Vishal Sandilya, Moyinoluwa Adeniyi, Jiepei Zhu, Yehia Mechref, Firas Kobeissy, et al.

    Background: Millimeter-wave directed energy (mmWave DE) is increasingly used in telecommunications and military applications, yet its biological effects remain unclear. Here, we characterized the spatially dependent cellular and molecular impacts of 34.14 GHz mmWave DE exposure on mouse neuroblastoma (N2A) cells. Methods: N2A cells were exposed to mmWave DE for 48 h, generating Center (direct exposure), Penumbra (peripheral exposure), and Control groups. Morphology was assessed by phase-contrast microscopy and F-actin staining; viability and membrane integrity were evaluated by MTT, LDH, and DAPI/PI assays. Cytoskeletal protein degradation (αII-Spectrin, Vimentin, Nestin) was examined by Western blot and immunocytochemistry. Label-free LC-MS/MS proteomics, Gene Ontology (GO), Ingenuity Pathway Analysis (IPA), and PathwayStudio were used to define global molecular responses. Results: Center-exposed cells showed severe morphological disruption, reduced viability ( p < 0.0001), increased LDH release, and marked membrane permeabilization, consistent with dominant necrotic injury. Western blotting revealed enhanced proteolysis of αII-Spectrin, Vimentin, and Nestin. Proteomic profiling identified 181 statistically significant dysregulated proteins in the Center and 34 in the Penumbra (adjusted p < 0.05); of these, 12 and 14 proteins, respectively, also met the high-effect threshold of |log₂FC| ≥ 1. These alterations converged on cytoskeletal organization, mitochondrial stress, RNA processing, and proteostasis. Conclusion: mmWave DE exposure induces a spatially graded injury response, ranging from adaptive stress signaling in the Penumbra to proteostasis collapse, cytoskeletal failure, and membrane injury in the Center. These findings support further mechanistic evaluation of mmWave bioeffects and their potential relevance to neuroinjury-related pathways.

  • Open Access

    Millimeter-Wave Directed Energy-Mediated Neural Cell Injury: Insights into Protein Degradation and Cell Injury Mechanisms

    by Mojtaba Golpich, Hamad Yadikar, Sherifdeen Onigbinde, Joy Solomon, Vishal Sandilya, Moyinoluwa Adeniyi, Jiepei Zhu, Yehia Mechref, Firas Kobeissy, Kevin K. Wang

    Background:Millimeter-wave directed energy (mmWave DE) is increasingly used in telecommunications and military applications, yet its biological effects on neuronal systems remain unclear. To characterize the spatially dependent cellular and molecular impacts of 34.14 GHz mmWave DE exposure on mouse neuroblastoma (N2A) cells as a model system. Methods: N2A cells were exposed to mmWave DE for 48 hours, generating three defined zones: Center (direct exposure), Penumbra (peripheral exposure), and Control. Morphological changes were evaluated by microscopy; viability and membrane integrity were assessed via MTT and LDH assays. Cytoskeletal protein degradation (αII-Spectrin, Vimentin) was measured by Western blot. Label-free LC-MS/MS proteomics, Gene Ontology (GO), Ingenuity Pathway Analysis (IPA), and Pathway Studio were used to define global molecular responses. Results:Center-exposed cells showed severe morphological disruption, reduced viability (p < 0.0001), and elevated LDH release, consistent with necrosis. Western blot revealed increased proteolysis of αII-Spectrin and Vimentin. Proteomic profiling identified >180 dysregulated proteins in the Center and 34 in the Penumbra, affecting cytoskeleton organization, mitochondrial function, and RNA processing. GO and IPA indicated activation of apoptosis, ER stress, and necrosis pathways, with inhibition of translation and cell movement. Pathway mapping linked DE-altered proteins to neurodegenerative and injury-relevant processes. Conclusion: mmWave DE exposure induces graded cellular injury, ranging from stress adaptation in peripheral regions to proteostasis collapse and structural failure in direct-hit zones. These findings support reconsideration of mmWave safety standards and highlight parallels with neurodegenerative mechanisms.

  • Open Access

    Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development

    by Bang Wang, Firas Kobeissy, Mojtaba Golpich, Guangzheng Cai, Xiaowei Li, Reem Abedi, William Haskins, Weihong Tan, Steven A. Benner, Kevin K. W. Wang

    Aptamers developed using in vitro Systematic Evolution of Ligands by Exponential Enrichment (SELEX) technology are single-stranded nucleic acids 10–100 nucleotides in length. Their targets, often with specificity and high affinity, range from ions and small molecules to proteins and other biological molecules as well as larger systems, including cells, tissues, and animals. Aptamers often rival conventional antibodies with improved performance, due to aptamers’ unique biophysical and biochemical properties, including small size, synthetic accessibility, facile modification, low production cost, and low immunogenicity. Therefore, there is sustained interest in engineering and adapting aptamers for many applications, including diagnostics and therapeutics. Recently, aptamers have shown promise as early diagnostic biomarkers and in precision medicine for neurodegenerative and neurological diseases. Here, we critically review neuro-targeting aptamers and their potential applications in neuroscience research, neuro-diagnostics, and neuro-medicine. We also discuss challenges that must be overcome, including delivery across the blood–brain barrier, increased affinity, and improved in vivo stability and in vivo pharmacokinetic properties.